|
||||||||||||
25 Jan 2012:: We now have a new download site: www.OmicsExpress.com
25 May 2011:: SVA is published in Bioinformatics.
21 Mar 2011:: SVA V1.10 is released: [1]Supports GRCh build 37/hg19; [2] Supports user annotation track in GFF3 or BED formats.
9 Sep 2010:: The characterization of twenty sequenced human genomes. [Article]
12 Jul 2010:: LabCorp Launches Interleukin 28B Polymorphism (IL28B) Genotype Test to Support Individualized Treatment Decisions for Patients with Hepatitis C Viral Infection.
17 Jun 2010:: Causal variants for metachondromatosis are identified. [Article] [SVA screenshot] [GenomeWeb: The Daily Scan]
18 Mar 2010:: SVA 1.02[beta] is released.
11 Mar 2010:: SVA 1.01[beta] is released with a command line tool.
8 Mar 2010:: A lite evaluation edition is released for Windows. Play with it on your laptop!
23 Jan 2010:: SVA 1.00[beta] is released.
|
SVA in action
Screenshot 1: SVA genome browser shows a frameshifting coding INDEL (insertion/deletion) in the Factor VIII (F8) gene on chromosome X. This coding variant causes the type A hemophilia in one of the sequenced patients. Screenshot 2: SVA Single Nucleotide Variant (SNV) list shows a premature stop SNV (stop-gained) in the Factor VIII (F8) gene on chromosome X. This coding variant causes the type A hemophilia in one of the sequenced patients. (The red highlighting arrow was later added to this screenshot.) Screenshot 3: SVA Insertion/Deletion (INDEL) list shows diverse frameshifting coding INDELs in the Factor VIII (F8) gene on chromosome X. Each of these distinct INDELs are carried by 1 or 2 patients, and cause the type A hemophilia. (The red highlighting arrow was later added to this screenshot.) Screenshot 4: SVA structural variation (SV) list shows a number of predicted deletions covering the whole length of some gene transcripts. These genes are usually pseudo-genes and/or these "functional" SVs are usually heterozygous (with only one strand of DNA deleted). Screenshot 5: SVA variant density view shows the density of genetic variants identified. Screenshot 6: SVA Gene Prioritization (SVA-GP) function ranks the Factor VIII (F8) gene as the first "possible candidate hit", by comparing 10 patient genomes with 10 control genomes. The 10 patients are type A hemophilia patients resistant to HIV infection. This project is funded by the The Bill & Melinda Gates Foundation to David Goldstein at Duke University Institute for Genome Sciences & Policy (IGSP), Center for Human Genome Variation. (Some pre-published data were manually masked in this screenshot.) Screenshot 7: SVA gene biotype filter. Screenshot 8: SVA biological pathway filter. Screenshot 9: SVA OMIM disorder filter. Screenshot 10: SVA gene filter. Screenshot 11: SVA variant quality score filter. Screenshot 12: SVA summary functions (under development). Screenshot 13: SVA analysis functions (under development). Screenshot 14: Another shot at SVA genome browser.
|
|||||||||||
| Visits: |
© 2011 |
||||||||||||